449 related articles for article (PubMed ID: 19164225)
21. Role of [
Xu Q; Liu R; Wang J; Huang Y; Li S; Zhang L; Wang F
Nucl Med Biol; 2020; 88-89():34-43. PubMed ID: 32688289
[TBL] [Abstract][Full Text] [Related]
22. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
[TBL] [Abstract][Full Text] [Related]
23. Preablation 131-I scans with SPECT/CT in postoperative thyroid cancer patients: what is the impact on staging?
Avram AM; Fig LM; Frey KA; Gross MD; Wong KK
J Clin Endocrinol Metab; 2013 Mar; 98(3):1163-71. PubMed ID: 23430789
[TBL] [Abstract][Full Text] [Related]
24. [Impact of 131I SPECT/CT on the management of differentiated thyroid carcinoma outpatients with radioablation].
Mizokami D; Kosuda S; Shiotani A; Kinoshita F; Saotome K; Morozumi K
Nihon Jibiinkoka Gakkai Kaiho; 2014 May; 117(5):673-80. PubMed ID: 24956745
[TBL] [Abstract][Full Text] [Related]
25. Integrated PET/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient management.
Palmedo H; Bucerius J; Joe A; Strunk H; Hortling N; Meyka S; Roedel R; Wolff M; Wardelmann E; Biersack HJ; Jaeger U
J Nucl Med; 2006 Apr; 47(4):616-24. PubMed ID: 16595495
[TBL] [Abstract][Full Text] [Related]
26. Hybrid SPECT/CT Imaging in the Management of Differentiated Thyroid Carcinoma.
Ahmed N; Niyaz K; Borakati A; Marafi F; Birk R; Usmani S
Asian Pac J Cancer Prev; 2018 Feb; 19(2):303-308. PubMed ID: 29479949
[TBL] [Abstract][Full Text] [Related]
27. Thallium-201 and iodine-131 scintigraphy in differentiated thyroid carcinoma.
Lorberboym M; Murthy S; Mechanick JI; Bergman D; Morris JC; Kim CK
J Nucl Med; 1996 Sep; 37(9):1487-91. PubMed ID: 8790199
[TBL] [Abstract][Full Text] [Related]
28. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
[TBL] [Abstract][Full Text] [Related]
29. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.
Lind P; Gallowitsch HJ; Langsteger W; Kresnik E; Mikosch P; Gomez I
J Nucl Med; 1997 Mar; 38(3):348-52. PubMed ID: 9074515
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma.
Mirallié E; Guillan T; Bridji B; Resche I; Rousseau C; Ansquer C; Bodet-Milin C; Curtet C; Carnaille B; Murat A; Charbonnel B; Kraeber-Bodéré F
Surgery; 2007 Dec; 142(6):952-8; discussion 952-8. PubMed ID: 18063081
[TBL] [Abstract][Full Text] [Related]
31. Combination of radioiodine (131I) and probe-guided surgery for persistent or recurrent thyroid carcinoma.
Travagli JP; Cailleux AF; Ricard M; Baudin E; Caillou B; Parmentier C; Schlumberger M
J Clin Endocrinol Metab; 1998 Aug; 83(8):2675-80. PubMed ID: 9709930
[TBL] [Abstract][Full Text] [Related]
32. RAI thyroid bed uptake after total thyroidectomy: A novel SPECT-CT anatomic classification system.
Zeuren R; Biagini A; Grewal RK; Randolph GW; Kamani D; Sabra MM; Shaha AR; Tuttle RM
Laryngoscope; 2015 Oct; 125(10):2417-24. PubMed ID: 25891354
[TBL] [Abstract][Full Text] [Related]
33. Comparison of ¹⁸F-fluoride PET/CT, ¹⁸F-FDG PET/CT and bone scintigraphy (planar and SPECT) in detection of bone metastases of differentiated thyroid cancer: a pilot study.
Ota N; Kato K; Iwano S; Ito S; Abe S; Fujita N; Yamashiro K; Yamamoto S; Naganawa S
Br J Radiol; 2014 Feb; 87(1034):20130444. PubMed ID: 24297809
[TBL] [Abstract][Full Text] [Related]
34. [The value of multimodal imaging by single photon emission computed tomography associated to X ray computed tomography (SPECT-CT) in the management of differentiated thyroid carcinoma: about 156 cases].
Mhiri A; El Bez I; Slim I; Meddeb I; Yeddes I; Ghezaiel M; Gritli S; Ben Slimène MF
Tunis Med; 2013 Oct; 91(10):589-93. PubMed ID: 24281999
[TBL] [Abstract][Full Text] [Related]
35. SPECT/CT imaging in children with papillary thyroid carcinoma.
Kim HY; Gelfand MJ; Sharp SE
Pediatr Radiol; 2011 Aug; 41(8):1008-12. PubMed ID: 21607603
[TBL] [Abstract][Full Text] [Related]
36. I-131 SPECT/CT elucidates cryptic findings on planar whole-body scans and can reduce needless therapy with I-131 in post-thyroidectomy thyroid cancer patients.
Blum M; Tiu S; Chu M; Goel S; Friedman K
Thyroid; 2011 Nov; 21(11):1235-47. PubMed ID: 22007920
[TBL] [Abstract][Full Text] [Related]
37. The clinical significance of remnant thyroid tissue in thyroidectomized differentiated thyroid cancer patients on
Wang F; Nie H; Li W; Zhang R; Li W
BMC Med Imaging; 2021 May; 21(1):78. PubMed ID: 33964885
[TBL] [Abstract][Full Text] [Related]
38. Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma.
Ruf J; Lehmkuhl L; Bertram H; Sandrock D; Amthauer H; Humplik B; Ludwig Munz D; Felix R
Nucl Med Commun; 2004 Dec; 25(12):1177-82. PubMed ID: 15640775
[TBL] [Abstract][Full Text] [Related]
39. Clinical approach in patients with metastatic differentiated thyroid carcinoma and negative 131I whole body scintigraphy: importance of 99mTc MIBI scan combined with high resolution neck ultrasonography.
Casara D; Rubello D; Saladini G; Mazzarotto R; Sotti G; Tomasella G; Pelizzo MR
Tumori; 1999; 85(2):122-7. PubMed ID: 10363078
[TBL] [Abstract][Full Text] [Related]
40. Erector spinae metastases from differentiated thyroid cancer identified by I-131 SPECT/CT.
Qiu ZL; Luo QY
Clin Nucl Med; 2009 Mar; 34(3):137-40. PubMed ID: 19352273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]